Blaze Bioscience is a biotechnology company developing products designed to assist cancer surgeons. Founded by Dr. Jim Olson, a pediatric neuro-oncologist at the Fred Hutchinson Cancer Research Center and Seattle Childrenâs Hospital, and Heather Franklin, a former senior business executive from ZymoGenetics and having close and ongoing ties to the Fred Hutchison Cancer Center, Blaze is working to develop Tumor Paint products and Optide-based guided cancer therapeutics.. Tumor Paint provides real-time, high resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors
